M&A Corner
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales11 Dec 2023
Abcam, a prominent life science research tools provider, finalized its acquisition by Danaher Corporation at $24.00 per share in cash.... Continue Reading
|
Oxford Biomedica Signs Agreement to Acquire ABL Europe from Institut Mérieux, Consolidating Position as a Global Pure-Play CDMO.11 Dec 2023
Oxford Biomedica is set to acquire ABL Europe, a European CDMO specializing in gene therapies and viruses, solidifying its position... Continue Reading
|
Biopharma Funding, Deals Fall Sharply in 2023 in ‘Strategic’ Shift:11 Dec 2023
The biopharmaceutical industry experienced a downturn in venture capital funding in 2023, set to reach $24 billion across 840 transactions,... Continue Reading
|
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering11 Dec 2023
ZyVersa Therapeutics, a biopharmaceutical company, prices a public offering of 4 million shares at $1.25 each, totaling $5 million in... Continue Reading
|
Cytovale Secures $84M for Transformative Sepsis Diagnostic Tool11 Dec 2023
Cytovale secures $84 million in Series C funding, led by Norwest Venture Partners, Sands Capital, and Global Health Investment Corporation.... Continue Reading
|
Roche Jumps into Lucrative Weight-Loss Space with $2.7B Carmot Buy11 Dec 2023
Roche’s $2.7 billion acquisition of Carmot Therapeutics forges a promising entry into the weight-loss market. The deal, expected in early... Continue Reading
|
R1 RCM Acquires Acclara for $675M, Secures 10-Year RCM Partnership with Providence Health System11 Dec 2023
R1 RCM, a healthcare tech solutions provider, acquires Acclara for $675M, solidifying its revenue cycle management stance and enhancing patient... Continue Reading
|
NuvoAir Partners with ALS Association to Launch Virtual Pulmonary Care Service11 Dec 2023
NuvoAir, a virtual care provider, joins forces with the ALS Association to offer virtual pulmonary care to ALS patients in... Continue Reading
|
Lifepoint Health and Ascension Saint Thomas Announce Joint Venture11 Dec 2023
Rural hospital chain Lifepoint Health and Ascension Saint Thomas form a joint venture to co-own Tennessee’s Highpoint Health, a four-hospital... Continue Reading
|
Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer11 Dec 2023
Absci Corporation and AstraZeneca join forces to utilize AI for an antibody targeting cancer treatment. Absci’s Integrated Drug Creation™ blends... Continue Reading
|